Evidence map›Paper›PMID 35078977›Full record

ArticleNature communications2022

Characterization of the COPD alveolar niche using single-cell RNA sequencing.

Maor Sauler, John E McDonough, Taylor S Adams, Neeharika Kothapalli, Thomas Barnthaler, Rhiannon B Werder, Jonas C Schupp, Jessica Nouws, Matthew J Robertson, Cristian Coarfa and 16 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 173 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
173citing papers in PubMed, 1 pooled it
18.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

173 citing papers in PubMed, 1 synthesis or guideline pooled it, 213 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Preclinical models of COPD: a state of the art review.The European respiratory journal · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. HHIP's dynamic role in epithelial wound healing reveals a potential mechanism of COPD susceptibility.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  20. Hallmarks of the ageing lung: 10 years later.The European respiratory journal · 2026
    Review

113 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 7 institutions in 6 countries.

Maor Sauler *Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA. maor.sauler@yale.edu.ORCID http://orcid.org/0000-0001-5240-7978
John E McDonough *Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA. john.e.mcdonough@yale.edu.
Taylor S AdamsPulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Neeharika KothapalliPulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Thomas BarnthalerPulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Rhiannon B WerderCenter for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, 02118, USA.
Jonas C SchuppPulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-7714-8076
Jessica NouwsPulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Matthew J RobertsonPulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX, USA.
Cristian CoarfaPulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX, USA.ORCID http://orcid.org/0000-0002-4183-4939
Tao YangPulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Maurizio ChioccioliPulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Norihito OmotePulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Carlos CosmePulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.
Sergio PoliDepartment of Internal Medicine, Mount Sinai Medical Center, Miami, FL, USA.ORCID http://orcid.org/0000-0001-5442-3189
Ehab A AyaubDivision of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Sarah G ChuDivision of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Klaus H JensenIntomics A/S, Lyngby, Denmark.ORCID http://orcid.org/0000-0003-3234-6068
Jose L GomezPulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-6521-6318
Clemente J BrittoPulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-1979-1151
Micha Sam B RaredonDepartment of Biomedical Engineering, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-1441-6122
Laura E NiklasonDepartment of Biomedical Engineering, Yale University, New Haven, CT, USA.
Andrew A WilsonCenter for Regenerative Medicine of Boston University and Boston Medical Center, Boston, MA, 02118, USA.
Pascal N TimshelIntomics A/S, Lyngby, Denmark.
Naftali Kaminski *Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0001-5917-4601
Ivan O Rosas *Pulmonary, Critical Care and Sleep Medicine, Baylor College of Medicine, Houston, TX, USA.
Yale University · USBaylor College of Medicine · USBoston University · USBrigham and Women's Hospital · USClinical Microbiomics (Denmark) · DKMedical University of Graz · ATMount Sinai Medical Center · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Study Support Suite (YES3): Dashboard and Web Portal Software Supporting Research Workflow through integrated, customizable REDCap External ModulesP30AG021342 · NIA · YALE UNIVERSITY · PI Albert C Shaw · 2002 to 2026
$37.9M
Respiratory Computational Discovery CoreP01HL114501 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI SILVERMAN, EDWIN K · 2013 to 2025
$24.9M
Scientific Human Biomarker Exposure Monitoring Core (HEMC) for the Air pollution disrupts Inflammasome Regulation in HEart And Lung Total Health (AIRHEALTH) StudyP01HL152953 · NHLBI · STANFORD UNIVERSITY · PI NADEAU, KARI C. · 2021 to 2025
$9.8M
Genomic Analysis of Tissue and Cellular Heterogeneity in IPFR01HL127349 · NHLBI · YALE UNIVERSITY · PI BENOS, PANAGIOTIS V, KAMINSKI, NAFTALI · 2015 to 2025
$5.9M
Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary FibrosisUH3TR002445 · NCATS · NATIONAL JEWISH HEALTH · PI DOWNEY, GREGORY PAUL, KAMINSKI, NAFTALI · 2019 to 2021
$5.0M
Systems Biology of a MicroRNA Network in Neutrophilic AsthmaR01HL153604 · NHLBI · YALE UNIVERSITY · PI GOMEZ-VILLALOBOS, JOSE LUIS · 2020 to 2024
$3.4M
Role of MIF and CD74 in the pathogenesis of emphysemaR01HL155948 · NHLBI · YALE UNIVERSITY · PI BUCALA, RICHARD J, SAULER, MAOR · 2021 to 2025
$3.4M
Epithelial Protective Effects of Thyroid Hormone Signaling in FibrosisR01HL141852 · NHLBI · YALE UNIVERSITY · PI KAMINSKI, NAFTALI · 2019 to 2022
$3.4M
Normal Aging Lung Cell Atlas (NALCA)U01HL145567 · NHLBI · YALE UNIVERSITY · PI KAMINSKI, NAFTALI · 2019 to 2022
$2.8M
Engineered Tracheal ReplacementsR01HL138540 · NHLBI · YALE UNIVERSITY · PI NIKLASON, LAURA E · 2017 to 2020
$2.5M
MIF and DNA repair in the emphysematous lungK08HL135402 · NHLBI · YALE UNIVERSITY · PI SAULER, MAOR · 2017 to 2021
$842k
Austrian Science Fund FWF J 4547NCATS NIH HHS UH3 TR002445NCATS NIH HHS UL1 TR001863NHLBI NIH HHS F30 HL143906NHLBI NIH HHS K08 HL135402NHLBI NIH HHS P01 HL114501NHLBI NIH HHS P01 HL152953NHLBI NIH HHS R01 HL127349NHLBI NIH HHS R01 HL138540NHLBI NIH HHS R01 HL141852NHLBI NIH HHS R01 HL153604NHLBI NIH HHS R01 HL155948NHLBI NIH HHS R03 HL154275NHLBI NIH HHS U01 HL145567NIA NIH HHS P30 AG021342
6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is a leading cause of death worldwide, however our understanding of cell specific mechanisms underlying COPD pathobiology remains incomplete. Here, we analyze single-cell RNA sequencing profiles of explanted lung tissue from subjects with advanced COPD or control lungs, and we validate findings using single-cell RNA sequencing of lungs from mice exposed to 10 months of cigarette smoke, RNA sequencing of isolated human alveolar epithelial cells, functional in vitro models, and in situ hybridization and immunostaining of human lung tissue samples. We identify a subpopulation of alveolar epithelial type II cells with transcriptional evidence for aberrant cellular metabolism and reduced cellular stress tolerance in COPD. Using transcriptomic network analyses, we predict capillary endothelial cells are inflamed in COPD, particularly through increased CXCL-motif chemokine signaling. Finally, we detect a high-metallothionein expressing macrophage subpopulation enriched in advanced COPD. Collectively, these findings highlight cell-specific mechanisms involved in the pathobiology of advanced COPD.

Indexed as

A549 CellsAlveolar Epithelial CellsAnimalsCells, CulturedCluster AnalysisEpithelial CellsFemaleGene Expression ProfilingGene Regulatory NetworksHumansLungMaleMiceMice, Inbred C57BLMice, TransgenicPulmonary Disease, Chronic Obstructive

Identifiers

PMID35078977
PMCPMC8789871
OpenAlexW4210263666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.